AGE-induced neuronal cell death is enhanced in G2019S LRRK2 mutation with increased RAGE expression

Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease

(2014) Mike A Nalls et al.   NATURE GENETICS

Effect of advanced glycation end product intake on inflammation and aging: a systematic review

(2014) Katrien Van Puyvelde et al.   NUTRITION REVIEWS

MicroRNA-205 regulates the expression of Parkinson's disease-related leucine-rich repeat kinase 2 protein

(2012) Hyun Jin Cho et al.   HUMAN MOLECULAR GENETICS

Advanced glycation endproducts as gerontotoxins and biomarkers for carbonyl-based degenerative processes in Alzheimer's disease

(2011) Anton Rahmadi et al.   CLINICAL CHEMISTRY AND LABORATORY MEDICINE

Converging environmental and genetic pathways in the pathogenesis of Parkinson's disease

(2011) Lena F. Burbulla et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Involvement of the cerebral cortex in Parkinson disease linked with G2019S LRRK2 mutation without cognitive impairment

(2010) Anna Gomez et al.   ACTA NEUROPATHOLOGICA

Advanced glycation endproducts and their pathogenic roles in neurological disorders

(2010) Gerald Münch et al.   AMINO ACIDS

Phosphorylation of Ezrin/Radixin/Moesin Proteins by LRRK2 Promotes the Rearrangement of Actin Cytoskeleton in Neuronal Morphogenesis

(2009) L. Parisiadou et al.   JOURNAL OF NEUROSCIENCE

Parkinson's disease

(2009) Andrew J Lees et al.   LANCET

Genome-wide association study reveals genetic risk underlying Parkinson's disease

(2009) Javier Simón-Sánchez et al.   NATURE GENETICS

Leucine-Rich Repeat Kinase 2 Regulates the Progression of Neuropathology Induced by Parkinson's-Disease-Related Mutant α-synuclein

(2009) Xian Lin et al.   NEURON

Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study

(2008) Daniel G Healy et al.   LANCET NEUROLOGY